Pamela McKay

Pamela McKay is an Honorary Clinical Associate Professor at the School of Cancer Sciences, University of Glasgow, specializing in Cancer Sci & Molecular Pathology. Her research focuses on hematological malignancies, particularly lymphoma treatment strategies and chemotherapy-related complications.

Recent studies led or co-authored by McKay examine

• CNS prophylaxis in DLBCL
• cardiotoxicity prevention during anthracycline therapy
• geriatric treatment protocols for Hodgkin lymphoma
• economic evaluations in aggressive B-cell lymphoma

. Her work bridges clinical practice, molecular pathology, and health economics.

Key article trends include

• optimizing high-dose methotrexate regimens
• advancing imaging techniques for toxicity assessment
• redefining staging evaluations in lymphoma

. All publications reflect her commitment to improving outcomes in hematological cancers.